Hassan Dakroub MD PC

Combination anti-HIV antibody infusions suppress virus for prolonged period
Date:
June 1, 2022
Source:
NIH/National Institute of Allergy and Infectious Diseases
Summary:
Individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), according to a small study. The findings suggest that combination bNAb therapy might offer a future alternative to daily ART for people living with HIV.

Full Story

Combination anti-HIV antibody infusions suppress virus for prolonged period Individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), according to a small study. The findings suggest that combination bNAb th...